Latka logo

Top 5 Drug Discovery Software Companies With $10M–$100M Revenue (September 2026)

As of September 2026, Latka tracks 5 drug discovery software companies with $10M–$100M in annual revenue. They have combined revenues of $185.3M and employ 635 people. They have raised $683.8M.

Every company below sells drug discovery software to other businesses and is ranked by its most recent annual revenue. Revenue, funding, headcount and customer figures come from CEO interviews on the Latka podcast, public company filings, and Latka estimates where a company has not disclosed a number.

What Drug Discovery Software Companies do

Drug Discovery Software encompasses a range of tools and applications that aid in the development of new pharmaceuticals. These solutions streamline the research process by enabling researchers to design, analyze, and optimize drug candidates more efficiently. Common use cases include target identification, lead optimization, and preclinical trials, wherein software facilitates simulations and predictions that guide decision-making during the drug discovery pipeline. Typically, drug discovery software features include molecular modeling, compound library management, virtual screening, and data analysis capabilities. Users of this software include pharmaceutical companies, biotech firms, and academic institutions focused on drug development. By automating complex processes, these tools help researchers reduce costs and timeframes associated with bringing new medicines to market.

Companies
5
Revenue
$185.3M
Funding
$683.8M
Employees
635

Filters

Sorting: Highest -> Lowest

Filters

Top Drug Discovery Software Companies With $10M–$100M Revenue

Showing 5 of 5 companies ranked by annual revenue.

1insitro logo
insitro

San Francisco, California, United States

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

Revenue
$69M
Year founded
2018
Funding
$643M
Team size
262
2AIgnostics logo
AIgnostics

Berlin, Berlin, Germany

Aignostics is an AI-powered precision diagnostics company that focuses on pathology to assist with drug development and clinical research. It specializes in transforming drug development and improving patient outcomes with AI that delivers novel insights for precision medicine.

Revenue
$45M
Year founded
2018
3Chemify Limited logo
Chemify Limited

Glasgow, Scotland, United Kingdom

Chemify is a chemistry and chemical discovery digitization platform. It develops a digitization platform to run chemical code for drug discovery, chemical synthesis, and materials discovery.

Revenue
$39.5M
Year founded
2019
Team size
126
4OPTIC logo
OPTIC

San Francisco, California, United States

AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation. Automating biotech R&D. About Optic Optic started as an AI research team developing high-performance similarity search algorithms. Today our proprietary AI-technology is powering products in multiple industries from blockchain to biotech.

Revenue
$19.9M
Year founded
2021
Team size
181
5Synthace logo
Synthace

London, England, United Kingdom

Developer of a cloud software platform designed to automate and improve the success rate of biological research and development. The company's platform uses artificial intelligence for designing and simulating biological systems, as well as methods of collating, structuring and analyzing experimental data, enabling clients to transfer biological designs into real 'wet lab' experiments via logistics simulation and execution seamlessly.

Revenue
$11.8M
Year founded
2011
Funding
$40.8M
Team size
66

Frequently asked questions about Drug Discovery Software Companies With $10M–$100M Revenue

How many drug discovery software companies with $10M–$100M in annual revenue are there?

Latka tracks 5 drug discovery software companies with $10M–$100M in annual revenue. Together they generate $185.3M in annual revenue and employ 635 people.

Which drug discovery software company with $10M–$100M in annual revenue is the largest?

insitro is the largest, with $69M in annual revenue, founded in 2018.

How much revenue does a typical drug discovery software company with $10M–$100M in annual revenue make?

The average drug discovery software company in this list makes $37.1M a year, across 5 companies with reported revenue.

Who are the leading Drug Discovery software vendors with $10M–$100M in annual revenue?

Ranked by annual revenue, the leaders are insitro, AIgnostics, Chemify Limited, OPTIC and Synthace.

How much funding have drug discovery software companies with $10M–$100M in annual revenue raised?

The 5 drug discovery software companies with $10M–$100M in annual revenue tracked here have raised $683.8M in disclosed funding between them.

Related Vertical Industry Software categories

Inclusion Criteria

- Offers tools for molecular modeling and simulations - Supports data analysis related to drug interactions and efficacy - Aids in target identification and validation in the drug discovery process - Includes features for library management of drug compounds - Must facilitate preclinical trial planning and analysis - Not just general research software; must specifically cater to drug discovery workflows